| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.gtbl.in | |
| Market Cap | 735.52 Cr. | |
| Enterprise Value(EV) | 723.17 Cr. | 2022-03 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 33.36 | Trailing Twelve Months Ending 2022-06 |
| Price-Earning Ratio (PE) | 15.17 | Trailing Twelve Months Ending 2022-06 |
| Industry PE | 32.29 | Trailing Twelve Months Ending 2022-06 |
| Book Value / Share | 83.35 | Trailing Twelve Months Ending 2022-06 |
| Price to Book Value | 6.07 | Calculated using Price: 506.25 |
| Dividend Yield | 2.17 | Period Ending 2022-03 |
| No. of Shares Subscribed | 1.45 Cr. | 14,528,702 Shares |
| FaceValue | 5 | |
| Company Profile | ||
| Gujarat Themis Biosyn Ltd, established in 1981, is a biotech and synthetic product manufacturing company, having plants at Vapi, Hyderabad, with group turnover of over $ 40 million. It has EDMFs, available and WHO approved plants.The company has world-wide exports to satisfied customers, having customised facility for all products.The company’s principal activity is to manufacture and distributes pharmaceuticals bulk drugs called rifampicin produced by fermentation process. The company's products include preparations of active pharmaceutical ingredient rifampicin and lovastatin. The company exports its products to Europe and the United States. | ||
| 1 Day |
|
+0.54% |
| 1 Week |
|
+0.13% |
| 1 Month |
|
+19.09% |
| 3 Month |
|
+19.09% |
| 6 Month |
|
+42.87% |
| 1 Year |
|
+17.84% |
| 2 Year |
|
+175.36% |
| 5 Year |
|
+1110.56% |
| 10 Year |
|
+5569.44% |
| 9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 302.71 | 72.63 | 38.06 | 41.85 | 77.99 | 53.82 | 50.35 | |||
| Return on Capital Employed (%) | 209.07 | 113.74 | 80.38 | 54.67 | 42.22 | 44.88 | 85.96 | 67.89 | 67.91 | |
| Return on Assets (%) | 26.54 | 29.88 | 31.50 | 24.25 | 18.45 | 24.07 | 45.62 | 35.65 | 37.08 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Shh. Funds | -10 | -5 | -1 | 4 | 8 | 12 | 19 | 42 | 70 | 103 | |
| Non Curr. Liab. | 7 | 6 | 6 | 2 | 1 | 0 | 1 | 5 | 2 | 2 | |
| Curr. Liab. | 21 | 15 | 10 | 9 | 12 | 8 | 13 | 24 | 26 | 32 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 18 | 16 | 15 | 15 | 21 | 20 | 33 | 71 | 98 | 137 | |
| Non Curr. Assets | 14 | 13 | 11 | 11 | 13 | 13 | 25 | 35 | 25 | 44 | |
| Curr. Assets | 4 | 3 | 3 | 3 | 8 | 8 | 8 | 36 | 73 | 93 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 18 | 16 | 15 | 15 | 21 | 20 | 33 | 71 | 98 | 137 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-06 Rs. Cr. TTM |
| Net Sales | 30 | 31 | 33 | 36 | 39 | 41 | 85 | 91 | 115 | 127 | |
| Other Income | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 3 | 4 | 4 | |
| Total Income | 30 | 32 | 33 | 36 | 39 | 43 | 87 | 94 | 119 | 132 | |
| Total Expenditure | -24 | -25 | -27 | -30 | -33 | -34 | -53 | -50 | -57 | -63 | |
| PBIDT | 7 | 6 | 6 | 6 | 6 | 10 | 34 | 44 | 62 | 68 | |
| Interest | -1 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | -1 | -1 | |
| Depreciation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -2 | -2 | -2 | |
| Taxation | -1 | -1 | -2 | -8 | -11 | -15 | -17 | ||||
| Exceptional Items | |||||||||||
| PAT | 5 | 5 | 5 | 4 | 4 | 6 | 24 | 30 | 44 | 48 | |
| Adjusted EPS | 3 | 3 | 3 | 3 | 3 | 4 | 16 | 21 | 30 | 33 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | 4 | 3 | 4 | 3 | 6 | 1 | 1 | 11 | 40 | |
| Cash Fr. Inv. | -3 | 0 | 0 | -1 | -3 | -1 | -6 | -3 | -2 | -30 | |
| Cash Fr. Finan. | 2 | -3 | -3 | -3 | 0 | -4 | 5 | 2 | -5 | -14 | |
| Net Change | 0 | 1 | -1 | 0 | 0 | 1 | 0 | 0 | 3 | -4 | |
| Cash & Cash Eqvt | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 4 | 0 |
|
Wed, 17 Aug 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation 2015 we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited has received below mentioned intimation / request(s) for Loss of Share Certificate(s) / issuance of duplicate share certificate(s) from the following shareholder(s):Sr. No. Name Folio No. Cert. No. Number of Shares Dist. No.From Dist. No.To1. K SUNDARARAJAN K000100 5477 50 1732951 1733000 We shall issue the duplicate Share Certificate(s) only after the necessary formalities are carried out by the Shareholder(s). |
|
Wed, 17 Aug 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication In terms of Regulation 47 of the SEBI (LODR) Regulations 2015 the Company has published the notice in Western Times (English) edition dated August 17 2022 & in Western Times (Gujarati) edition dated August 17 2022 which includes the following information; a) Intimation of 41st Annual General Meeting (AGM) of our Company to be held through video conferencing / other audio-visual means and confirmation of dispatch of Annual Report for the Financial Year 2021-22 along with Notice of the AGM.b) Particulars of the facility of e-voting provided to Members of the Company to enable them to cast their votes on the resolutions proposed to be passed at the AGM.Further in pursuance of Regulation 30 read with Schedule III (A) (12) please find enclosed the copy of Newspaper articles as published in above mentioned newspapers. |
|
Tue, 16 Aug 2022
Reg. 34 (1) Annual Report. Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith a copy of the Annual Report of the Company for the financial year ended 31st March 2022 along with the Notice convening the 41st Annual General Meeting (AGM) to be held on Wednesday September 7 2022 at 12:00 Noon through Video Conferencing (VC)/Other Audio Visual Means (OAVM). |
| Thu, 18 Aug 2022 |
Higher Delivery Quantity
|
Higher Trade Quantity
|
Higher Trade and Delivery Quantity
|
High Increase 1 Month
|
High Increase 3 Months
|
Equities
M.F.
Sectors